Drug Side Effects
Search
PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH
0 reported adverse events
Drug classes:
Endoglycosidase [EPC]
Programmed Death Receptor-1 Blocking Antibody [EPC]
These side effects are most commonly reported by patients taking PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH:
#
Side effect
Count
See all common reactions for PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH
PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH is most commonly taken among patients reporting these side effects:
#
Side effect
Count
Frequency
See all enriched reactions for PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH